Back
Beyond Meat, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Sell
43
BYND
Beyond Meat, Inc.
Last Price:
$1.04
Seasonality Move:
-5.55%
Buy
58
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$399.52
Seasonality Move:
1.76%
Sell
43
Beyond Meat, Inc. (BYND)
is a Sell
Is Beyond Meat, Inc. a Buy, Sell or Hold?
-
The current Beyond Meat, Inc. [BYND] share price is $1.04. The Score for BYND is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BYND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Buy
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $422.50. The Score for ALNY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BYND Stock Price Chart
What is Beyond Meat, Inc.'s stock price today?
-
The Beyond Meat, Inc. share price today is $1.04The current trend is relatively stagnant and BYND is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $422.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BYND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 49.76 | Sell |
| Chaikin Money Flow: | 52413722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.93 - 1.23) | Sell |
| Bollinger Bands (100): | (1 - 2.56) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.11 | Sell |
| Relative Strength Index (14 RSI): | 55.51 | Buy |
| Chaikin Money Flow: | 823719 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (389.12 - 440.9) | Buy |
| Bollinger Bands (100): | (421.2 - 470.34) | Sell |
BYND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Buy |
| 20-day SMA: | 1.04 | Sell |
| 50-day SMA: | 1.21 | Sell |
| 200-day SMA: | 2.43 | Sell |
| 8-day EMA: | 0.95 | Buy |
| 20-day EMA: | 1.01 | Buy |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 2.47 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 402.72 | Buy |
| 20-day SMA: | 402.95 | Buy |
| 50-day SMA: | 432.63 | Sell |
| 200-day SMA: | 373.51 | Buy |
| 8-day EMA: | 405.72 | Buy |
| 20-day EMA: | 409.93 | Buy |
| 50-day EMA: | 424.3 | Sell |
| 200-day EMA: | 384.64 | Buy |
Beyond Meat, Inc. Earnings Growth & BYND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.22 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.09 per share, and an increase next year of $6.72 per share.
Beyond Meat, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||